Pfizer To Buy 8.1% Stake In French Vaccines Company Valneva

Pfizer has agreed to invest €90.5 million ($95.25 million) in an 8.1% stake in Valneva to boost the two companies’ development of a vaccine against Lyme disease.

The U.S.  pharmaceutical giant will buy Valneva (ticker: VALN.France) at a price of €9.49 per share, via a reserved capital increase, according to a statement.

Shares in Valneva ,…

 » Read More  » Read More

Tags: No tags

Comments are closed.